This research activity was aimed at the development of composite bioactive scaffolds made of biodegradable three-arm branched-star poly(ε-caprolactone) ( * PCL), hydroxyapatite nanoparticles (HNPs) and clodronate (CD), a bisphosphonate that has demonstrated efficacy in the treatment of various bone diseases and as an anti-inflammatory drug. During the experimental work, the processing conditions for the fabrication of fibrous meshes, by either electrospinning or wetspinning, were optimized. Stemming from a previous research activity on electrospinning of * PCL, * PCL/HNPs 3D meshes were developed, evaluating the influence of fabrication parameters on the fibres' morphology. By exploiting the binding affinity of bisphosphonates for hydroxyapatite, a methodology was set up for obtaining a physical linkage between CD and HNPs, with the aim of having a dual bioactive system loaded into * PCL fibrous mats. Fibres loaded with either CD or CD-HNP particles were thus produced and analysed by scanning electron microscopy for their morphology and by energy dispersive X-ray spectroscopy for their elemental composition.
Introduction
Bisphosphonates (BPs) are a class of bioactive agents inhibiting bone resorption and ectopic calcification, widely used in the therapy of diseases caused by altered metabolism of bone tissue, such as Paget's disease, tumour-associated osteolysis and hypercalcaemia, osteoporosis and primary hyperparathyrosis (Ezra and Golomb, 2000; Rogers et al., 2000; Martin and Grill, 2000) .
or/and by affecting the metabolic activities of osteoblasts (Rogers et al., 2000; Van Beek et al., 2002; Horie et al., 2003) .
The major disadvantages associated with systemic use of the clinically employed BPs are poor absorption and adverse gastrointestinal effects in oral administration therapy as well as local tissue damage and irritation at the injection site (Ezra and Golomb, 2000) . A localized and controlled BP delivery system can allow for improved bioavailability and safety. It has been reported that a topical treatment allows for overcoming limitations associated to systemic use, with the advantages of having a controlled therapeutic dosage in the region of interest and BP distribution to avascular areas in necrotic bone tissue (Astrand and Aspenberg, 2004) . Implanted BP-releasing systems can be employed for the optimization of hypercalcaemia treatment in tumourinduced osteolysis (Ezra and Golomb, 2000) and to improve the local effect in confined dental bone surgery (Nafea et al., 2008) . Furthermore, providing implantable bioabsorbable systems with BP-releasing features can prevent osteolytic lesions caused by the inflammatory processes induced by polymer degradation products (Huolman and Ashammakhi, 2007) .
Various BPs releasing systems for bone applications have been developed such as coatings for titanium or stainless-steel screws (Tengvall et al., 2004) , BPcomplexed HA implants (Denissen et al., 1997 (Denissen et al., , 2000 , BPs combined to frozen cancellous bone allografts (Jeppsson et al., 2003) and BP-releasing poly(lactic-co-glycolic) rods for bone fixation (Huolman and Ashammakhi, 2007) . The possibility of BP encapsulation into microparticles made of chitosan (Samdancioglu et al., 2006; Patashnk et al., 2009) or poly(lactic-co-glycolic acid) (Perugini et al., 2001; Weidenauer et al., 2003; Nafea et al., 2008) has been also reported.
Poly(ε-caprolactone) (PCL) is a semicristalline polymer that has been widely proposed for bone regeneration application because of its biocompatibility and degradation properties (Williams et al., 2005; Koh et al., 2006; Rai et al., 2007; Puppi et al., 2010a) . In biological conditions, it can be degraded by microorganisms as well as by hydrolytic mechanisms and its slow degradation rate can be tuned to match with bone tissue ingrowth (Hutmacher, 2000; Savarino et al., 2007) . However, the implantation of polymer substitutes into bone defects typically presents various drawbacks, such as lack of immediate adhesion to the surrounding tissue because of an inflammatory reaction, encapsulation into fibrous tissue and mechanical strength reduction associated with material degradation (Taylor et al., 1994; Kokubo et al., 2003; Schiller and Epple, 2003) . The incorporation of HA particles into polymer matrices has been investigated as an effective means of improving the osteoconductivity and mechanical properties of bone implants and create a pH buffer against the acidic degradation products of the polymeric matrices (Ural et al., 2000; Kikuchi et al., 2004; Kim et al., 2004; Koh et al., 2006; Puppi et al., 2010a) . This research activity was aimed at the development of new BP-releasing bioabsorbable scaffolds for bone tissue-engineering applications. Clodronic acid disodium salt (clodronate, CD), an efficient anti-osteolytic agent with approved clinical record and low rate of adverse events (Selander et al., 1996; Fleisch, 2000; Huolman and Ashammakhi, 2007) , was chosen in this study as a BP model. CD has also demonstrated efficacy as anti-inflammatory agent and in stimulating osteoblast differentiation in osteoblast-like and pluripotent mesenchymal cell culture (Horie et al., 2003; Itoh et al., 2003) . The three-dimensional (3D) carriers developed within this experimental project are polymeric and composite fibrous meshes produced by either electrospinning or wet-spinning techniques. Since fibre dimension and mesh porosity can greatly affect drug release kinetics, our aim was to develop BP-loaded polymeric meshes with a different structural scale and texture by employing the two techniques mentioned. A three-arm branched star poly (ε-caprolactone) ( * PCL) (Balakrishnan et al., 2004 (Balakrishnan et al., , 2006 , a biocompatible polymer which has been already investigated for the production of electrospun fibrous meshes for tissue engineering applications (Puppi et al., 2010b) , was employed. The processing conditions for the production of * PCL meshes loaded with either HA nanoparticles (HNPs) or CD were optimized and correlated to mesh morphology. Exploiting the binding affinity of BPs for HA (Rogers et al., 2000; Leu et al., 2006) , a methodology for obtaining a physical linkage between CD and HNPs was investigated. The incorporation of particles of such complex into * PCL fibres was also studied in order to introduce a further control over drug release as well as to increase the osteoconductivity of polymer meshes. The meshes produced were characterized for their morphology by scanning electron microscopy (SEM) and for composition by energy dispersive X-ray spectroscopy (EDS).
Materials and methods

Materials
Three-arm branched star poly(ε-caprolactone) ( * PCL, MW 189 000 Da) was kindly supplied by Michigan Biotechnology Institute; HA nanoparticles (HNPs, size <200 nm) were bought from Sigma-Aldrich and clodronic acid disodium (CD) was kindly supplied by Abiogen Pharma-Pisa (Italy). All the solvents and chemical reagents were purchased from Sigma-Aldrich (Italy) and used as received. room temperature. CD binding efficiency was evaluated by measuring the free CD in the supernatant. Free CD was complexed with copper ions (Cu 2+ ) in nitric acid solution, and its concentration was determined by ultraviolet spectrophotometry (UV) at 236 nm (standard curve, 0.025-1.0 mM; R 2 = 0.993) as described by Ostović et al. (1993) . The binding efficiency (η) of the physical reaction between CD and HNPs was calculated as follows:
where CD i is the input drug and CD f is the free drug in the supernatant.
Development of fibrous meshes by either electrospinning or wet-spinning
Polymer and composite fibrous meshes were produced by processing plain * PCL solutions or suspensions of HNPs, CD or CD-HNP particles in * PCL solution, respectively. The processing conditions for the production of fibres by either electrospinning or wet-spinning were investigated. The prepared meshes were analysed for their morphology and composition by SEM and EDS, respectively.
2.3.1. Preparation of polymer solutions and polymer/CD/HNP mixtures * PCL was dissolved in acetone at 40 • C, under gentle stirring for 2 h to obtain homogeneous solutions of various concentrations. For the production of composite fibres, CD, HNPs or CD-HNP particles were added to the polymer solution and left under vigorous stirring for 2 h to achieve their homogeneous dispersion.
On the base of some preliminary investigations, the weight ratio between HNPs and * PCL in solutions for the production of fibres loaded with either HNPs or CD-HNP particles, was chosen to be 25% by weight. Therefore, considering the binding efficiency between CD and HNPs, the theoretical weight ratio between CD and * PCL in the solutions for the production of fibres loaded with CD-HNPs was 0.075. This value was employed also for the fabrication of CD-loaded * PCL fibres.
Production of electrospun fibre meshes
A 15% w/v * PCL solution was placed in a syringe equipped with a metallic needle, with an inner diameter (i.d.) of 0.84 mm, and the solution feeding rate was controlled by a syringe pump (KDS100, KD Scientific, MA). Using a semi-commercial high-voltage power supply, an electric field was applied between the metallic needle of the syringe and an electrical grounded aluminium collector. The applied voltage was 25 kV and the distance from the needle tip to the collector 15 cm. The variation of the processing conditions for the production of * PCL meshes was evaluated in order to optimize the fibres mesh morphology. In particular, the influence of solution feed rate was investigated in the range 1-16 ml/h. The electrospun mats were removed, placed in a vacuum chamber for at least 48 h to allow the evaporation of the residual organic solvent and then stored in a desiccator.
Production of 3D wet-spun fibre meshes
A polymer solution was loaded into a plastic syringe (5 ml) with a metallic needle (0.5 mm i.d.) attached to it. The syringe was connected to a programmable syringe pump (KD Scientific, World Precision Instruments, UK) to inject the polymer solution at controlled pumping rate to allow the formation of non-woven web directly into the coagulation bath. The non-woven web was formed during the processing by the random movement of the coagulation bath. Various processing parameters, such as solvent, polymer concentration, coagulation bath and solution flow rate, were varied to optimize fibre morphology. Either acetone or chloroform was employed as solvent and methanol, ethanol and water were tested for the coagulation bath. Spun meshes were left in the coagulation bath for 24 h, then removed, placed in a vacuum chamber for 48 h and finally stored in a desiccator.
Scanning electron microscope (SEM) and energy dispersive X-ray spectroscopy (EDS) analysis
Samples were gold-coated using a sputter-coater set at 15 mA for 20 min and mesh morphology was investigated by using SEM instruments (Leica 360; FEI Nova 200). Mesh elemental composition was investigated by EDS analysis (EDAX Pegasus X4M), based on the energy and intensity distribution of X-ray signals generated by the electron beam striking the surface of the specimen. Three random areas (300 × 400 µm) of each sample were analysed for their elemental composition.
Results and discussion
Development of CD-HNPs complex
The high affinity of BPs for HA, due to their ability to form a 3D structure with divalent metal ions (Rogers et al., 2000; Leu et al., 2006) , is the basis of their bonetargeting property. A few recent experimental studies have proposed HA as the carrier for the controlled delivery of BPs adopting different strategies, such as incorporation of BPs into HA crystals (McLeod et al., 2006; Boanini et al., 2007) or BP-HA physical binding (Seshima et al., 2006; Ong et al., 2008) .
In the present study, we investigated a straightforward simple method for obtaining a physical binding between CD and HNPs with η (yield) of around 15%. Figure 1 shows micrographs of HNPs and CD powders as well as that of CD-HNPs powder, recovered after centrifugation EDS analysis of the recovered CD-HNPs powders showed the presence of chlorine (Cl) and sodium (Na), correlated to the presence of CD, and calcium (Ca), associated to HNPs (Figure 1d ). Moreover, from comparison among spectra of different randomly taken fields, it appears that CD was uniformly distributed along powder specimens (data not shown).
Development of * PCL-based electrospun meshes
In the last 10 years, electrospinning has been gaining a widespread interest for applications in drug delivery and tissue engineering. Electrospinning enables great flexibility in materials selection, drug-loading methods and choice of the appropriate loading agent. These, together with various inherent features of electrospun meshes (such as high surface area : volume ratio and high and interconnected porosity), can enhance drug loading and mass transfer properties, offering a broad spectrum of advanced design solutions for the fine control of drug release kinetics Detta et al., 2010) . In the last years a few studies have investigated the possibility of incorporating therapeutic and bioactive agents into electrospun fibres without affecting mesh morphology and the bioactivity of loaded agents (Cui et al., 2006; Piras et al., 2006; Xie and Wang, 2006; Xu et al., 2006; Zheng-Ming et al., 2006; Nie and Wang, 2007; Maretschek et al., 2008; Piras et al., 2008; Puppi et al., 2009) . Moreover, electrospun mats composed of randomly orientated fibres with diameters down to the nanometer scale are suitable for replicating the physical structure of the extracellular matrix of biological tissues, and they have been shown to influence in vitro cell adhesion, proliferation and phenotypic behaviour (Bhattarai et al., 2004; Shin et al., 2004; Fujihara et al., 2005; Badami et al., 2006; Stitzel et al., 2006; Martins et al., 2007 Martins et al., , 2009a Martins et al., , 2009b Araujo et al., 2008; da Silva et al., 2008; Pinho et al., 2009) .
During the present research activity, we investigated the processing of suspensions of HNPs, CD or CD-HNPs in * PCL solution by applying the electrospinning conditions optimized in a previous related study on * PCL electrospun fibres (15% w/v polymer concentration, V = 25 kV and d = 15 cm) (Puppi et al., 2010b) and by studying the influence of solution feed rate on mesh morphology.
* PCL/HNPs electrospun meshes
In the recent years, a few published works have reported the inclusion of HA particles into electrospun polymer fibres as means for improving mesh osteoconductivity and mechanical properties (Ito et al., 2005; Hae-Won et al., 2006; Catledge et al., 2007; Dai and Shivkumar, 2007) . As shown in Figures 2a-c , the addition of HNPs to the electrospinning solution led to the formation of fibre morphology defects. By increasing the feed rate, the formation of defects in the analysed meshes was inhibited. EDS analysis confirmed the presence (Figure 3a) and the homogeneous distribution of phosphorus (P) and Ca correlated to HNPs loading.
CD-loaded
* PCL electrospun meshes SEM analysis of electrospun CD-loaded * PCL meshes showed a fibrous structure characterized by fibre defects, in the form of beads along the fibres (Figures 2d-f ). Both the number per unit area and the size of beads were gradually decreased by decreasing the solution feed rate from 16 ml/h to 1 ml/h. EDS analysis was performed to investigate whether heterogeneous drug distribution was responsible for mesh defects and to analyse the beads' composition. Spectra of CD-loaded meshes displayed low-energy peaks corresponding to the elements of CD (Figure 3b ). This can be related to the low amount of CD added to the polymer solution and/or to the distribution of the drug in the fibre section. Moreover, there were no remarkable differences between the composition of fibres and beads, indicating that the formation of such defects was due to the electrospinning setting, which initially was not optimized, and not to a heterogeneous drug distribution into the mesh microstructure.
* PCL meshes loaded with CD-HNP particles
Fibrous meshes loaded with CD-HNP particles were produced with no remarkable influence of the feeding rate on fibre morphology (Figure 2g, h) . Figure 3c shows a representative EDS spectrum of this kind of mesh; comparing the EDS spectra taken from different areas in the same sample, the elements composing both CD (P, Cl, Na) and HNPs (P, Ca) were uniformly distributed in the analysed meshes. However, some microaggregates ( Figure 2i ) with morphology similar to that observed in CD-HNPs powder ( Figure 1c) were observed in highmagnification micrographs. EDS analysis revealed that these microaggregates were mainly composed of the elements of CD and HNPs (Figure 3d ). The presence of such microaggregates, mainly composed of CD-HNP particles not incorporated into * PCL fibres, may influence the release kinetics of the loaded meshes, contributing to a possible initial burst release.
Development of wet-spun meshes
Wet-spinning is a non-solvent-induced phase inversion technique allowing for polymer fibre production through an immersion-precipitation process. In detail, a continuous polymer fibre is produced by precipitation of a polymer solution filament in a coagulation bath composed of a poor solvent (non-solvent) or a non-solvent-solvent mixture with respect to the processed polymer. An homogeneous solution filament, composed of polymer, solvent and possible additives, solidifies because of polymer desolvation, caused by solvent-non-solvent exchange.
A number of studies have reported the development of wet-spun fibres made of natural polymers, such as (Tuzlakoglu et al., 2004; Tuzlakoglu and Reis, 2008) and regenerated silk fibroin (Yao et al., 2001; Um et al., 2004; Lee et al., 2007) . In recent years, some research has proposed wet-spun fibres as carriers for drug release, such as either chitosan (Denkbas et al., 2000) or PLLA fibres (Gao et al., 2007) loaded with 5-fluorouracil. This technique was also proposed to develop scaffolds for tissue-engineering applications, based in PCL fibres (Williamson and Coombes, 2004) , braided PLLA or chitosan fibres (Zhang et al., 2007) and starch-based fibres (Tuzlakoglu et al., 2009) .
During this experimental activity, the wet-spinning process for obtaining the * PCL-based wet-spun fibres loaded with HNPs, CD or CD-HNPs were investigated by improving the processing conditions, such as the solvent-non-solvent system, polymer concentration and solution feed rate.
* PCL wet-spun meshes
The production of fibrous meshes by wet-spinning was tested with * PCL solutions and two different solvents (acetone and chloroform), as well as various polymer concentrations (10-20% w/v) and three different nonsolvents (methanol, ethanol, water), to optimize the processing conditions. When chloroform was employed as solvent, proper polymer coagulation was not achieved for any of the above-mentioned non-solvents. Employing acetone as solvent and ethanol as non-solvent, phase inversion took place, allowing for the coagulation of the spun solution in the form of a polymer fibre. In this case, the polymer concentration giving by the best fibre morphology was found to be 15% w/v. The influence of solution flow rate on fibre morphology was further studied in the range 1.5-3.5 ml/h. The results showed that the fibres' morphology was improved when using the flow rate of 1.75 ml/h (Figure 4a ). This condition produced a fibre diameter in the range 100-250 µm and a porous fibre structure with a pore size of few micrometers (Figure 4b, c) . Moreover, the fibres looked fused at fibre-fibre contact points, forming a cohesive non-woven web. Upon immersion of a polymer solution into a coagulation bath, the non-solvent diffuses into the polymer solution, whereas the solvent diffuses into the bath. Solvent-non-solvent counter-diffusion lowers the polymer solubility and induces a phase separation into a polymer-rich phase and a polymer-lean phase. A dense polymer matrix surrounding the dispersed polymer-lean droplets, which will form the pores, is consequently formed. Usually a dense, non-porous layer, due to the instantaneous non-solvent diffusion into the polymer solution, is observed at the interface with the coagulant Mchugh, 1990, 1992; Wienk et al., 1996) . As reported in the literature, the formation of a spongy morphology with a porous surface interfacing with the coagulating fluid is due to delayed liquid-liquid demixing (Wienk et al., 1996; Barton et al., 1997) .
What is observed in the SEM micrographs of wet-spun * PCL fibres, concerning both the porous morphology of the fibre outer surface and the bonding at the fibre-fibre contact points, indicates that in our case the inversion phase process was governed by delayed precipitation and that the filament was not completely solidified when it settled at the bottom of the bath container.
On the basis of this preliminary investigation, the optimized processing conditions were 15% w/v polymer concentration, acetone as solvent, ethanol as non-solvent and 1.75 ml/h flow rate. The composition of the starting suspensions selected for the production of * PCL fibres loaded with HNPs, CD or CD-HNP particles was the same as that already employed for the electrospinning technique.
3.3.2.
* PCL/HNPs wet-spun meshes 3D fibrous meshes of * PCL/HNPs composite fibres were fabricated by the coagulation of a filament of HNPs suspension in the polymer solution. SEM analysis from * PCL/HNPs meshes revealed a more narrow fibre size distribution, comparing to bare polymer matrices, with fibre diameters in the range 100-200 µm. In addition, * PCL/HNPs meshes showed a less porous surface and no fusion between fibres at the crossing points (Figure 5a, b) . It is known that the additives loaded into polymer solution may have an effect on the final morphology of the polymeric porous systems produced by phase inversion. Their presence is mainly reflected on both process thermodynamics and kinetics (Strathmann et al., 1975; Reuvers and Smolders, 1987; Mulder, 1996; Kim and Lee, 1998) .
In this case, a possible effect of the addition of HNPs to polymer solution could be a faster solidification of the filament, generating a less porous fibre morphology.
In a speculative manner, this phenomenon may be attributed to a pre-existing interaction between polymer and additive, which indeed has an effect on polymer solvation and consequently on the coagulation process. Figure 5c shows a representative EDS spectrum of HNPs-loaded * PCL fibres. Chemical composition analysis of fibre surface revealed the presence and homogeneous distribution of P and Ca elements, unequivocally associated with the presence of HNPs.
CD-loaded
* PCL wet-spun meshes
The possibility of producing wet-spun fibres loaded with bioactive agents has been shown in a few studies over recent years (Denkbas et al., 2000; Gao et al., 2007; Chang et al., 2008) . In the present study, 3D CD-loaded fibre meshes were successfully produced by coagulation of a filament of CD/ * PCL suspension (Figure 5d, e) . The addition of CD had a remarkable influence on mesh morphology: the fibre dimensions changed to a wider diameter range (150-350 µm) and no fusion was observed between fibres at the crossing points. The reduced surface porosity and the absence of fibre-fibre fusion suggest that a faster liquid-liquid demixing takes place in comparison to the processing of bare polymer fibres. EDS analysis (Figure 5f ) confirmed the presence and the homogeneous distribution of CD diagnostic atomic elements (Na, P and Cl). In addition, some white spots were observed on the fibre surfaces and they were analysed for their elemental composition to determine whether they were mainly composed of elements of CD. The small differences in intensity of analogue energy peaks in the spectra of the wide fibre surface areas and the white spots revealed that there was no significant drug segregation onto the fibre surface.
Wet-spun fibres loaded with CD-HNP particles
By processing a suspension of CD-HNP particles in * PCL solution, composite meshes with fibre diameters in the range 100-200 µm were produced. As shown by SEM analysis (Figure 5g, h) , the fibre surface was characterized by a porous morphology and appeared to be covered with aggregates of CD-HNP particles. This was confirmed by EDS analysis of the fibre surface, showing high-energy peaks associated with elements composing CD and HNPs (Na, Cl, P and Ca) (Figure 5i) . Similarly to what was observed for fibres loaded with either HNPs or CD, the surface porosity was reduced in comparison with unloaded fibres and the fibres did not show fusion at the crossing points.
General remarks on the results achieved
This section aims to provide a generalized discussion of the techniques utilized for the production of 3D polymeric scaffolds.
By applying the two different techniques investigated, we obtained 3D meshes composed of * PCL fibres with different texture scales and loaded with bioactive agents for potential application in bone repair. In both cases, the addition of loading agents (HNPs, CD or CD-HNPs) to the polymer solutions affected the morphology of the final fibrous structure. In detail, the addition of either HNPs or CD led to the formation of defects along the electrospun fibres, which could be minimized by varying the solution feed rate and affected the wet-spinning solidification process, causing changes in mesh morphology in terms of fibre-fibre contact point, fibre diameter and fibre porosity. In the case of meshes produced from suspensions of CD-HNP particles, aggregates mainly composed of CD and HNPs elements, which were not incorporated into polymer fibres, were observed in both electrospun and wet-spun samples. The inclusion of CD-HNP particles into fibres may present advantages over the loading of CD alone, such as an increase in osteoconductivity, due to the presence of the inorganic phase, and the introduction of a further control over CD release kinetics because of the physical binding between CD and HA. However, the presence of such microaggregates should be taken into consideration when studying drug release kinetics, because it may influence the behaviour of the loaded meshes, contributing to a possible initial burst in the release profile. In addition, such aggregates may cause great loss of the drug and the inorganic phase due to their solubilization or leaching during the pre-treatment stages before in vivo implantation (e.g. sterilization, in vitro scaffold preconditioning) causing a decrease of the actual loading of the implant.
During this study, it was observed that the developed electrospun fibres have a diameter of a few micrometers, while wet-spun fibres have a diameter of a few hundred micrometers. As the diameter of polymeric fibres shrinks, a much larger specific surface area can result, and the ratio of the polymer chains and of possible functional groups exposed to the surrounding environment can proportionally increases. As a consequence, more binding sites to cell membrane receptors are available, favouring cell attachment and proliferation, and mass transport phenomena throughout the fibrous construct are enhanced, improving cell nutrients and waste exchange (Zhang et al., 2005; Detta et al., 2010) . In addition, such influence on the mechanism and/or kinetics of the transport processes in the porous system will likely increase the material degradation rate and the release kinetics of loaded bioactive factors. However, it should be taken into account that the non-woven ultra-fine fibre structure typical of electrospun meshes presents pores in the nanometer scale, or in any case with the pore dimensions not larger than few micrometers. It is possible that this factor limits cell migration through the mesh, such that nanofibre constructs have been also proposed as an effective means to prevent post-surgery abdominal adhesion by providing a barrier function (Sill and von Recum, 2008) . In addition, electrospinning enables polymeric meshes with a thickness not larger than few millimeters to be obtained, while wet-spun constructs can have a thickness of some centimeters. In order to combine the advantages of each kind of fibre and minimize the aforementioned concerns, it would be interesting to combine the electrospun and wet-spun fibres developed during this study into a multi-scale network structure. Previous studies on such tissue-engineering scaffolds showed that electrospun ultrafine fibres can enhance the biological performance of the 3D microfibrous structure (obtained by either wet-spinning or rapid prototyping), which provides the required mechanical stability (Tuzlakoglu et al., 2005; Martins et al., 2009a) . Moreover, on the hypothesis that the remarkable difference in fibre diameter between electrospun and wet-spun fibres significantly affects mass transfer phenomena, by modulating the ratio between these two kinds of fibres constituting a multi-scale construct it would be possible to vary the release kinetics.
Another aspect to be considered is the need for improvement of the wet-spinning process employed during the present study for the production of 3D structures. Considering that the non-woven morphology was obtained through a continuous random motion of the coagulation tank made by hand, the final fibrous texture depends on the ability of the operator, and the process can be tiring (a scaffold of 5 mm in thickness is produced in around 30 min, applying the processing conditions optimized in this study). The employment of an automated system for computer control of the tank motion could significantly increase the production efficiency and improve the reproducibility of the mesh morphology. This is an important issue for future research activity.
Conclusions
Considering the multifunctional biological activity of BPs, we believe that a BP-releasing feature can greatly improve the performance of tissue-engineering scaffolds in inhibiting bone resorption associated with various bone diseases, such as tumour-associated altered bone metabolism or osteoporosis. It would play a main role in preventing osteolytic lesions caused by polymer degradation products, inhibiting post-implantation inflammatory reactions, and in stimulating bone regeneration. This research activity was aimed at the set-up of optimal conditions for the production of CD-loaded biodegradable fibrous scaffolds. In order to have control over the release kinetics of the active agent through the tuning of fibre dimensions and mesh porosity, we have developed fibrous mats with different structural scales and textures, by applying either electrospinning or wet-spinning techniques. * PCL, a novel star branched polymer, was investigated for the production of CD-releasing fibre meshes. Moreover, in order to introduce a further control over drug release based on CD affinity for HA, we developed a methodology for the obtainment of CD-HNP complex particles, achieving 15% binding affinity. Composite * PCL fibre meshes, obtained by processing suspensions of either HNPs or CD-HNP particles in polymer solution, were successfully produced. The inclusion of the active agents into polymer fibres influenced mesh morphology in the case of both electrospinning and wet-spinning. EDS analysis confirmed the presence of the active agents, loaded into the fibrous meshes. The developed methodologies appear simple and operator-friendly and led to highly reproducible results.
The study is presently ongoing for evaluation of the applicability of the developed meshes as scaffolds for bone repair and tissue engineering. All the prepared scaffolds are currently under characterization for their biodegradation profile, drug release kinetics, mechanical properties, biocompatibility and osteoconductivity.
